Key facts
- SyrhaTech’s last known valuation is $18.9M (Apr 2025).
- It has raised $8.6M; the latest was Later Stage VC ($5.1M) in Apr 2025.
- Notable investors include Fongit.
- Status: Privately Held (backing).
Investors
1- ·The complete investor list — 1 names
- ·Watchlist + deal alerts for SyrhaTech
- ·The full record, as it builds
Funding rounds
No funding rounds for SyrhaTech are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About SyrhaTech
Developer of injectable medical devices designed for medical applications. The company develops viscoelastic alternatives for aesthetic dermatology, orthopedics, and ophthalmology, and offers contract development and manufacturing services with high performance, quality, and competence, enabling clients to formulate their customized products using technological and scientific formulation assistance.
- Sector
- Healthcare
- HQ
- Geneva, Switzerland
- Founded
- 2018
- Employees
- 21
- Website
- syrhatech.com/
- Ownership
- Privately Held (backing)
SyrhaTech doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in SyrhaTech shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on SyrhaTech in its N-PORT filings yet. We sweep new filings monthly.